James Thomas
Partner
James
is a co-founder of Thomas, McNerney & Partners and has been investing in
health care companies since 1992. James previously headed Warburg Pincus
LLC's medical technology private equity practice, where he had responsibility
for investments in biotechnology, pharmaceutical, medical device and
diagnostic companies. Prior to
joining Warburg, James was a Vice President at Goldman Sachs International
in London. He is currently a
board member of
Clarus Therapeutics, Inc. Historical investments include:
American Medical
Systems Holdings, Inc. (AMMD),
CAS Medical Systems, Inc. (CASM sold to
Edwards Lifesciences), Coley Pharmaceutical Group, Inc. (COLY sold to Pfizer),
Galil Medical Ltd. (sold to BTG),
The Medicines Company (MDCO),
OsteoBiologics, Inc. (sold to Smith &
Nephew),
PCI Pharma Services, Inc. (sold to
Partners Group),
Torax Medical, Inc. (sold to Johnson &
Johnson), Transkaryotic Therapies, Inc. (TKTX sold to Shire
Pharmaceuticals Group),
Visible Genetics, Inc.,
Wright Medical Group, Inc. (WMGI),
and
Xomed Surgical Products, Inc. (XOMD
sold to Medtronic).
James graduated magna cum laude with a B.S. in Economics from the
Wharton School at the University of Pennsylvania and received an M.Sc. in
Economics from the London School of Economics.